Company Name: InflaRx N.V.

InflaRx N.V. is a clinical stage biopharmaceutical company. The company is engaged in the development of C5a inhibitors.

Ticker Symbol: IFRX (NASDAQ)

Company Website: http://www.inflarx.com

Headquarters: Jena, Germany